CH325834A - Process for the production of primary alcohols of the vitamin A series - Google Patents
Process for the production of primary alcohols of the vitamin A seriesInfo
- Publication number
- CH325834A CH325834A CH325834DA CH325834A CH 325834 A CH325834 A CH 325834A CH 325834D A CH325834D A CH 325834DA CH 325834 A CH325834 A CH 325834A
- Authority
- CH
- Switzerland
- Prior art keywords
- vitamin
- series
- production
- primary alcohols
- acid halides
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 7
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 150000003138 primary alcohols Chemical class 0.000 title claims description 4
- 150000002266 vitamin A derivatives Chemical class 0.000 title description 6
- 239000002253 acid Substances 0.000 claims description 18
- 150000004820 halides Chemical class 0.000 claims description 13
- 125000005843 halogen group Chemical group 0.000 claims description 3
- 125000004429 atom Chemical group 0.000 claims description 2
- 229910052751 metal Inorganic materials 0.000 claims description 2
- 239000002184 metal Substances 0.000 claims description 2
- 229910052987 metal hydride Inorganic materials 0.000 claims description 2
- 150000004681 metal hydrides Chemical class 0.000 claims description 2
- 239000000126 substance Substances 0.000 description 6
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 5
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 5
- 235000019155 vitamin A Nutrition 0.000 description 5
- 239000011719 vitamin A Substances 0.000 description 5
- 229940045997 vitamin a Drugs 0.000 description 5
- -1 Lithium aluminum hydride Chemical compound 0.000 description 4
- 239000012280 lithium aluminium hydride Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N EtOH Substances CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002140 halogenating effect Effects 0.000 description 2
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- OBWAFSRXIGEEKA-YCNIQYBTSA-N (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoyl chloride Chemical compound ClC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OBWAFSRXIGEEKA-YCNIQYBTSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- GANNOFFDYMSBSZ-UHFFFAOYSA-N [AlH3].[Mg] Chemical compound [AlH3].[Mg] GANNOFFDYMSBSZ-UHFFFAOYSA-N 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical compound [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 150000001277 beta hydroxy acids Chemical class 0.000 description 1
- MOOAHMCRPCTRLV-UHFFFAOYSA-N boron sodium Chemical compound [B].[Na] MOOAHMCRPCTRLV-UHFFFAOYSA-N 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000004370 vitamin A ester derivatives Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
- C07C403/06—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
- C07C403/08—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
<B>verfahren zur Herstellung primärer</B> Alkohole <B>der</B> Vitamin-A-Reihe Es ist bekannt, dass der Aufbau des das Vitamin A. kennzeichnenden Systems konju. gierter Doppelbindungen Schwierigkeiten be reitet. Soweit die betreffenden Synthesen unter gegebenenfalls mit Ally lumlagerung kombinierter Wasserabspaltung verlaufen, können verschiedene, sieh in der Lage der Doppelbindungen unterscheidende Isomere entstehen.
Diese Isomeren werden hier unterteilt in so;:enannte normale und iso -Verbindun- gen. Unter normalen Verbindungen sind im folgenden Stoffe zu verstehen, in denen ein dem Vitamin A (Formel 1) entsprechendes System konjugierter Doppelbindungen vor liegt. Ein solcher Stoff ist beispielsweise das f-Jonyliden-äthanol (Formel 2). Unter iso - Verbindungen sind Stoffe zu verstehen, deren Anordnung der Doppelbindungen eine andere ist. als diejenige des Vitamins A. Solche Stoffe sind z.
B. die Verbindungen der Formeln 3 und'4.
In der Bildung von solchen Isomeren wurde die Erklärung gesucht für die verhältnismässig geringen Ausbeuten an ss-Jonyliden-essigsätire- äthylester bzw. an Vitamin-A-Ester mit dem normalen System konjugierter Doppelbin dungen bei der Herstellung dieser Stoffe aus ss-.Tonon und Monobromessigsätire-äthylester bzw. aus ss-.Tonyliden-acetaldehyd und y-Brom- #,niethyl-crotonsäureäthylester. Es ist bekannt (siehe z.
B. das Schweizer Patent Nr. 324432 der Anmelderin), dass bei der Überführung bestimmter, gegebenenfalls aus normalen und iso -Formen bestehen den Säuren in Säurehalogenide ausschliesslich oder doch nahezu ausschliesslich nur die normalen Säurehalogenide erhalten werden. Dies trifft. z. B. zu bei der Herstellung der Säurehalogenide der Formel:
EMI0001.0037
wobei n - 1. oder 2 und Hlg ein Halogenatom darstellt.
Die vorliegende Erfindung bezieht sich nun auf ein Verfahren zur Herstellung primärer ; Alkohole aus der Vitamin-A-Reihe, wobei von Säurehalogeniden der vorstehend ange gebenen Formel ausgegangen wird.
Das erfindungsgemässe Verfahren ist da durch gekennzeichnet, dass Säurehalogenide der Formel
EMI0001.0043
wobei n 1 oder 2 und Hlg ein Halogenatom bedeutet, zu Alkoholen der Formel
EMI0002.0002
mittels eines zwei Metallatome enthaltenden Metallhydrids reduziert werden.
Als Reduktionsmittel wird beispielsweise Lithium-Aluminiumhydrid, Natrium-Bor- hydrill oder Magnesium-Aluminiumhydrid ver wendet. Von den Säurehalogeniden kommen insbe sondere Säurechloride oder Säurebromide als Ausgangsstoffe in Frage. .
Säurehalogenide von ss-Jonyliden-essigsäure oder von Vitamin-A-Säure lassen sieh aus den entsprechenden Säuren mit. geeigneten Halo- genierungsmitteln, wie Phosphortrichlorid oder Thionylehlorid, herstellen.
Es ist auch möglich, die erwähnten Säure halogenide gemäss dem im Schweizer Patent. Nr. 324432 der Anmelderin beschriebenen Verfahren herzustellen. CTemäss dem dort be schriebenen Verfahren werden bestimmte ss Hvdroxv-earbonsäuren der Vitamin-A-Reihe mit Halogenierungsmitteln, wie Phosphortri- chlorid oder Thionylehlorid, unter Wasser abspaltung in die Säurehalogenide umgesetzt.
Die Reduktion von Säurehalogeniden zu den entsprechenden primären Alkoholen ist. an sich bekannt. Auch ist das Reduktionsver fahren mit Lithium-aluminiumhydrid oder ähnlichen Hydriden bereits beschrieben wor den. Die Reduktion von Säurehalogeniden der Vitamin-A-Reihe wurde jedoch noch nicht be schrieben. Es ist weiterhin zu erwähnen, dass Lithium-aluminiumhydrid schon vorgeschlagen wurde, um Ester von Vitamin-A-Säure zu Vitamin A zu reduzieren.
Der Gedanke, Säurehalogenide der vorstehend angegebenen Formel zur Synthese primärer Alkohole der Vitamin-A-Reihe zii verwenden, ist jedoch in der Literatur noch nicht beschrieben worden. <I>Beispiel 1</I> 25,3 g (= 0,1 Mol) j3-Jonyliden-essigsäure- chlorid wurden in absolutem Äther in Lö sung gebracht und nach Abkühlen bis auf 0 C tropfenweise einer gleichfalls auf 0 C abgekühlten ätherischen Lösung von 2,3 g Li- thium-aluminiumhydrid zugesetzt.
Das Reak tionsgemisch wurde eine halbe Stunde lang bei dieser Temperatur gehalten und darauf vorsichtig mit Wasser versetzt. Die wässrige Schicht wurde abgetrennt und die ätherische Schicht nach Trocknen mit Natriumsulfat einer Destillation unterworfen. Der Rückstand bestand aus 20 g (= 0,09 Mol) ss-Jonyliden- äthanol. Das j?ltraviolettabsorptionsspektrum einer Lösung des Stoffes in Äthanol wies :Ma xima, bei 2650 Ä (e = 13200) und 2400 A (e = 12900) auf.
Beispiel <I>,2</I> Auf ähnliche Weise wie im Beispiel 1 wurde V itamin-A-Säureehlorid in ätherischer Lö sung bei angenähert 0 C mit Lithilini-alu- miniumhvdrid zu Vitamin A reduziert.
<B> Process for the production of primary </B> alcohols <B> the </B> vitamin A series It is known that the structure of the system characterizing vitamin A. Yawed double bonds cause difficulties. Insofar as the syntheses in question proceed with elimination of water, optionally combined with allyl rearrangement, various isomers differing in the position of the double bonds can arise.
These isomers are subdivided here into: called normal and iso compounds. In the following, normal compounds are to be understood as substances in which a system of conjugated double bonds corresponding to vitamin A (formula 1) is present. One such substance is, for example, f-Jonylidenethanol (Formula 2). Iso compounds are to be understood as meaning substances whose arrangement of the double bonds is different. than that of vitamin A. Such substances are z.
B. the compounds of formulas 3 and 4.
In the formation of such isomers, the explanation was sought for the relatively low yields of ss-Jonyliden-Essigsätire- ethyl ester or of vitamin A esters with the normal system of conjugated double bonds in the production of these substances from ss-.Tonon and Monobromessigsätire ethyl ester or from ss-.Tonylidene acetaldehyde and y-bromine #, niethyl-crotonic acid ethyl ester. It is known (see e.g.
B. Swiss Patent No. 324432 of the applicant) that when converting certain acids, possibly consisting of normal and iso forms, into acid halides only or almost exclusively only normal acid halides are obtained. This is true. z. B. to in the preparation of the acid halides of the formula:
EMI0001.0037
where n - 1. or 2 and Hlg represents a halogen atom.
The present invention now relates to a method of making primary; Alcohols from the vitamin A series, based on acid halides of the formula given above.
The process according to the invention is characterized in that acid halides of the formula
EMI0001.0043
where n is 1 or 2 and Hlg is a halogen atom, to alcohols of the formula
EMI0002.0002
be reduced by means of a metal hydride containing two metal atoms.
Lithium aluminum hydride, sodium boron hydride or magnesium aluminum hydride, for example, are used as reducing agents. Of the acid halides, special acid chlorides or acid bromides are particularly suitable as starting materials. .
Acid halides of ß-jonylideneacetic acid or of vitamin A acid leave the corresponding acids with. suitable halogenating agents such as phosphorus trichloride or thionyl chloride.
It is also possible to use the acid halides mentioned in the Swiss patent. No. 324432 of the applicant described method. According to the process described there, certain ss hydroxy acids of the vitamin A series are converted into the acid halides with halogenating agents, such as phosphorus trichloride or thionyl chloride, with elimination of water.
The reduction of acid halides to the corresponding primary alcohols is. known per se. The reduction process with lithium aluminum hydride or similar hydrides has already been described. However, the reduction of acid halides of the vitamin A series has not yet been described. It should also be mentioned that lithium aluminum hydride has already been proposed to reduce esters of vitamin A acid to vitamin A.
The idea of using acid halides of the formula given above for the synthesis of primary alcohols of the vitamin A series zii, however, has not yet been described in the literature. <I> Example 1 </I> 25.3 g (= 0.1 mol) of j3-ionylidene acetic acid chloride were dissolved in absolute ether and, after cooling down to 0 C, an ethereal solution, which was likewise cooled to 0 C, was dropped Solution of 2.3 g of lithium aluminum hydride added.
The reaction mixture was kept at this temperature for half an hour and then water was carefully added. The aqueous layer was separated, and the ethereal layer was subjected to distillation after drying with sodium sulfate. The residue consisted of 20 g (= 0.09 mol) of ß-Jonyliden- ethanol. The light ultraviolet absorption spectrum of a solution of the substance in ethanol showed: Maxima, at 2650 Å (e = 13200) and 2400 Å (e = 12900).
Example <I>, 2 </I> In a manner similar to that in Example 1, vitamin A acid chloride was reduced to vitamin A in an ethereal solution at approximately 0 ° C. with lithilini aluminum hydride.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL325834X | 1953-01-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH325834A true CH325834A (en) | 1957-11-30 |
Family
ID=19784168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH325834D CH325834A (en) | 1953-01-22 | 1953-11-27 | Process for the production of primary alcohols of the vitamin A series |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH325834A (en) |
-
1953
- 1953-11-27 CH CH325834D patent/CH325834A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE1543427A1 (en) | Process for the preparation of derivatives of 3,3-dimethylheptene- (5) -carboxylic acid | |
| CH325834A (en) | Process for the production of primary alcohols of the vitamin A series | |
| CH637618A5 (en) | METHOD FOR PRODUCING ANTHRACHINONE. | |
| AT207049B (en) | Process for the production of primary alcohols of the vitamin A series | |
| CH447147A (en) | Process for the preparation of 5- (3-hydroxypropyl) -5H-dibenzo (a, d) cycloheptenes | |
| AT372080B (en) | METHOD FOR PRODUCING NEW OPTICALLY ACTIVE PROST-5-EN-13-IN-CARBONIC ACID DERIVATIVES | |
| DE2041908A1 (en) | Trisubstituted ethylene derivatives | |
| AT216680B (en) | Process for the production of vitamin A. | |
| DE2936416C2 (en) | ||
| DE604640C (en) | Process for the production of vinyl esters | |
| DE894691C (en) | Process for the preparation of vitamin A-effective polyene carboxylic acids, their esters, vitamin A alcohols or their esters | |
| DE957943C (en) | Process for the preparation of 3-methyl-3-carboxycyclohexanone- (l) -2 - /? - propionic acid and derivatives thereof | |
| DE817460C (en) | Process for the preparation of a vinyl acetate derivative CHO | |
| DE1620513A1 (en) | Morphinans with rings B and C condensed in the trans position and processes for their preparation | |
| DE1101399B (en) | Process for the preparation of tertiary, monohydric diolefin alcohols | |
| DE1805676B2 (en) | PROCESS FOR THE PREPARATION OF CIS PROPENYLPHOSPHONIC ACID, ITS SALT OR ESTER | |
| CH412933A (en) | Process for the preparation of 2,5,7,8-tetramethyl-2- (2'-carboxy-ethyl) -chroman-6-ol | |
| CH363022A (en) | Process for the production of primary alcohols of the vitamin A series | |
| CH299186A (en) | Process for the production of a new polyethylene glycol derivative. | |
| DE1151809B (en) | Process for the production of appetite-suppressing ª ‰ -phenylalkylamines | |
| CH260994A (en) | Process for the production of vitamin A acid. | |
| CH476677A (en) | Process for the preparation of 5-hydroxy-5- (3-tertiary-aminopropyl) derivatives | |
| CH229776A (en) | Process for the preparation of pregnendione benzylenol ether. | |
| CH228089A (en) | Process for the preparation of 2,6-phytadienoic acid. | |
| CH250807A (en) | Process for the preparation of a new oxyhydrophenanthrene derivative. |